Collagen XVII/BP180, an epithelial adhesion molecule, belongs to the group of collagenous transmembrane proteins, which are characterized by ectodomain shedding. We recently showed that ADAMs can cleave collagen XVII, but also that furin participates in this process (Franzke, C. W., Tasanen, K., Schä cke, H., Zhou, Z., Tryggvason, K., Mauch, C., Zigrino, P., Sunnarborg, S., Lee, D. C., Fahrenholz, F., and Bruckner-Tuderman, L. (2002) EMBO J. 21, 5026 -5035). To define the cleavage region in the juxtamembranous NC16A linker domain and assess its structure and requirements for shedding, we constructed deletion mutants of the NC16A domain, expressed them in COS-7 cells, and analyzed their structural integrity and shedding behavior. A mutant lacking the furin consensus sequence was shed in a normal manner, demonstrating that furin does not cleave collagen XVII but rather activates ADAMs (a disintegrin and metalloproteinase). Large deletions of the NC16A domain prevented shedding, and analysis of defined smaller deletions pointed to the stretch of amino acid residues 528 -547 as important for sheddase recognition and cleavage. Secondary protein structure predictions showed that deletion of this stretch resulted in an NC16A domain with a positive net charge and an amphipathic ␣-helix, which can cause conformational changes in the collagen XVII homotrimer. Assessment of triple-helix folding of the mutants revealed a lower thermal stability of all non-shed variants than of wild-type collagen XVII or the shed mutants. In contrast, deletion of the putative nucleation site for triple-helix folding of collagenous transmembrane proteins did not affect folding of collagen XVII. The data indicate that the conformation of the NC16A domain and steric availability of the cleavage site influence shedding and is important for folding of collagen XVII.
Collagen XVII (also called BP180 or BPAG2), a hemidesmosomal protein in the skin, belongs to the emerging group of collagenous transmembrane proteins (1) . Currently the group includes collagens XIII, XVII, and XXIII and the brain-specific collagen XXV/CLAC precursor, ectodysplasin A, the class A macrophage scavenger receptors and the macrophage receptor with collagenous domain receptor (2) (3) (4) (5) (6) (7) . These proteins share a number of structural features, such as transmembrane location in type II orientation, an extracellular juxtamembranous linker domain with a coiled-coil structure motif, and one or more collagenous domains within the ectodomain, which can be shed from the cell surface to yield a soluble shorter molecule. Functionally, the proteins are involved in a broad spectrum of biological events, ranging from cell adhesion to host defense and are associated with the etiopathogenesis of genetic and acquired human diseases, including junctional epidermolysis bullosa, hypohidrotic ectodermal dysplasia, pemphigoids, and Alzheimer disease (5, 8 -10) .
Collagen XVII, the largest transmembrane collagen, is a heterotrimer of three 180-kDa ␣1(XVII) chains, each with an intracellular N-terminal domain of 466 amino acids, a short transmembrane stretch of 23 amino acids, and an extracellular C-terminal ectodomain of 1008 amino acids (3) . The ectodomain consists of 15 collagenous subdomains (COL1-COL15), characterized by typical collagenous GXY repeat sequences and flanked by 16 short non-collagenous sequences (NC1-NC16A). 1 The overall structure is flexible, rod-like, and triple-helical, with a significant thermal stability (11) (12) (13) . The extracellular linker domain, NC16A, between the plasma membrane and the COL15 domain is functionally important, because it is believed to play a role in both shedding and triple-helix folding of collagen XVII (13) (14) (15) .
Currently, the identification of the physiologically relevant sheddases for collagenous transmembrane proteins is pursued in several laboratories, but a unified concept has not emerged so far. Experimental evidence exists for cleavage of recombinant collagens XIII and XXV and of ectodysplasin A by furin in vitro (4, 5, 16, 17) . We have recently shown that shedding of authentic collagen XVII in keratinocytes can be catalyzed by members of the ADAMs (a disintegrin and metalloproteinase) family (18) . The ADAMs are themselves integral membrane proteins, which after activation by furin act close to the cell membrane in the extracellular space. They are involved in the release of a number of type I or type II transmembrane proteins. The cleavage of the precursors is believed not to require * This work was supported in part by grants from the Academy of Finland, the Alexander von Humboldt Foundation, and the Oulu University Hospital (to K. T.), from the Swiss National Foundation Scientific Research (Grant 32-56727.99 to L. B.), from the Commission of the European Communities (Grant CT 2001-02007 to L. B. and L. B.-T.), grants from the Deutsche Forschungsgemeinschaft (German Research Council, Grants SFB 293-B3, SFB 620-C5, and Br 1475/6 -2 to L. B.-T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
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The cleavage of collagen XVII occurs within the NC16A domain (11, 18) . However, the scissile bond has remained elusive, presumably due to secondary modifications, which render the newly generated N terminus of the ectodomain unamenable to amino acid sequencing (18) . Here we expressed recombinant full-length collagen XVII and mutants with different deletions in the NC16A domain to identify requirements for ADAM recognition and for trimerization and folding of collagen XVII.
EXPERIMENTAL PROCEDURES

Construction of Eukaryotic Expression Vectors Encoding Wild-type
Collagen XVII and Deletion Mutants-The full-length cDNA for human collagen XVII was generated as described previously (20) and cloned into the NotI site of pcDNA3 (Invitrogen). To generate the first eight deletion constructs (Table I) , the full-length expression vector was first digested with NdeI and ClaI restriction enzymes to remove the fragment spanning the nucleotides 1018 -2548 of human collagen XVII (GenBank TM accession number M911669). The eight cDNA fragments (Tables I and II) with defined deletions within the NC16A domain (amino acids 490 -566, nucleotides 1573-1803) were obtained using PCR with Dynazyme (Finnzymes, Espoo, Finland) and the full-length collagen XVII cDNA as a template. To remove the deleted sequences, two PCR fragments were first amplified from each site of the deletion and then ligated together to a fragment with the desired deletion in the middle. The forward primer used for the 5Ј part of all deletion fragments was primer D1 and the reverse primer for the 3Ј part of all constructs was D2 and, in addition, for each construct two other primers with additional PvuI site were used (Table II) . Next, the resulting two PCR products were purified using the QIAquick gel extraction kit (Qiagen, Hildesheim, Germany), digested with PvuI, and ligated. Finally, the cDNA fragments containing the deletions were digested with NdeI and ClaI, purified as above and re-ligated with NdeI/ClaI-digested pcDNA3 vector containing the full-length collagen XVII, which lacked nucleotides 1018 -2548. The four additional deletion constructs were generated using the GeneTailor site-directed mutagenesis system (Invitrogen) according to the manufacturer's recommendation and primers shown in Table II . Construct DEL527-531 was used as a template for DEL527-536 and DEL535-540 for DEL535-546. The resulting deletions and all amplicons were confirmed by DNA sequencing.
COS Cell Culture and Transfections-For transfection, the COS-7 cells were grown in DMEM containing 10% fetal calf serum. Semiconfluent cells were transfected with the DEAE-dextran method using 10 g of DNA/10-cm culture dish. In co-transfection experiments, 10 g of collagen XVII cDNA and, in some experiments, 10 g of full-length murine TACE cDNA (a kind gift from Jacques Peschon, Immunex Corp., Seattle, WA) were used. Transfected cells were grown in serumfree medium containing 50 g/ml ascorbic acid, which was added every 24 h to allow for hydroxylation of collagen and proper triple-helix formation. The media were collected 48 h after transfection, and processed, in parallel with the cell layers, as described (11) . Normal human keratinocytes were used as controls.
For experiments with protease inhibitors, COS-7 cells were seeded on 6-well plates at a density of 4 ϫ 10 4 cells/cm 2 and transfected with 0.4 g of DNA/well and Effectene (Qiagen, Hilden, Germany) according to the manufacturer's recommendations. The cells were washed 48 h post-transfection, changed to serum-free media, and incubated with the inhibitors for 6 h. Thereafter, the cell layer and medium were analyzed with immunoblotting. The following protease inhibitors were used: AEBSF (4-(2-aminoethyl)benzolsulfonylfluoride hydrochloride; Merck), 1,10-ortho-phenolanthroline, aprotinin, benzamidine, E-64 (L-3-carboxy-2,3-trans-epoxypropionylleucylamido(4-guanidino)butane, pepstatin A (Sigma), and the furin inhibitor decanoyl-Arg-Val-Lys-Argchloromethylketone (Calbiochem-Novabiochem GmbH). The hydroxamate inhibitors BB-3103 and BB-3241 were from British Biotech Ldt., TIMP-3 was from Chemicon International Ldt. (Hofheim, Germany), and the selective gelatinase inhibitor H-Cys-Thr-Thr-His-Trp-Gly-PheThr-Leu-Cys-OH (21) was from Bachem (Heidelberg, Germany).
RNA Interference-For interference with the expression of the TACE/ADAM-17 gene, the SureSilencing TM siRNA kit was used (BIOMOL GmbH, Hamburg, Germany). The siRNA populations targeting different regions of the TACE gene were transfected according to the manufacturer's recommendations using LipofectAMINE 2000 TM (Invitrogen). The highest silencing efficiencies were obtained by two subsequent transfections with TACE siRNA populations. In short: 1 day before transfection 2.5 ϫ 10 5 COS-7 cells were seeded in a well of a 6-well plate and cultured in DMEM with 10% FCS. Then the cells were transfected by addition of 2 g of TACE-specific siRNA per well. After 48 h, after washing once with PBS, the cells were co-transfected with 2.5 g of collagen XVII cDNA and 2 g of TACEspecific siRNA per well. After additional 24 h, fresh DMEM with 10% FCS and 50 g/ml ascorbate was added, and 48 h post-transfection, the shedding assay was started (18) . Efficient silencing of the TACE gene was confirmed by immunoblot analysis.
Immunofluorescence Microscopy and Immunoblotting-For immunofluorescence microscopy, COS-7 cells transfected with or without an expression vector coding for full-length collagen XVII were fixed and immunostained essentially as described (22) . NC16A antibody (10) was used as a primary antibody and Cy3-labeled goat anti-rabbit IgG (Jackson ImmunoResearch, Inc., West Grove, PA) as a secondary antibody.
For immunoblotting, the proteins were separated on SDS-PAGE on 7% or 12% polyacrylamide gels under reducing conditions (1 mM dithiothreitol). Immunoblotting was performed with collagen XVII antibodies Endo-2 (18), NC16A (10), Col15-2 (10), Ecto-5 (18), and Ecto-1 (11) . In addition, TACE antibodies against the extracellular pro-and metalloproteinase domains (Santa Cruz Biotechnology Inc., Heidelberg, Germany) and the intracellular C terminus (Chemicon International, Hofheim, Germany); antibodies to ADAM-10 endodomain (Chemicon International), and ADAM-9 ectodomain (R&D Systems GmbH, Wiesbaden, Germany) were used. Semiquantitation of immunoblot signals was obtained with scanning and analysis with Quantity One software (Bio-Rad).
Immunoprecipitation-The ectodomain of collagen XVII were immunoprecipitated from the culture medium of transfected COS-7 cells. First, it was cooled on ice, supplemented with 1 mM Pefabloc (Merck) and 1 mM N-ethylenemaleimide (Sigma), and clarified from debris by centrifugation with 200 ϫ g for 5 min. Prior to immunoprecipitation, 0.2 g of Protein A-Sepharose (Amersham Biosciences) was prepared as indicated by the supplier, washed once with PBS, once with PBS-0.5% Tween and once again with PBS. Then 50 l of the NC16A antibody was added to Protein A-Sepharose in 0.5 ml of PBS and rotated 3 h at 4°C. The Protein A-Sepharose-antibody complex was washed three times as above, and 30 ml of medium was added to antibody complexes and rotated at 4°C overnight. After three washes as above, the pellet was transferred at room temperature to a small column, using 50 mM Tris-HCl, pH 7.0, as column buffer. After extensive washing using the same buffer, the ectodomain of collagen XVII was eluted using 6 ml of 0.1 M glycine buffer, pH 3.0, at room temperature, and the fractions were neutralized immediately with 1 M Tris-HCl, pH 9.0, after elution.
For immunoprecipitation of the transmembrane collagen XVII forms, cell extracts were used. Prior to immunoprecipitation, 0.2 g of Protein A-Sepharose (Amersham Biosciences) was coupled with 100 l of Endo-2 antibody as described by the supplier. The cell lysates were precleared with protein A-Sepharose for 30 min and centrifuged at 2000 ϫ g for 5 min. The supernatants were incubated with antibody Endo-2/protein A-Sepharose complexes at 4°C overnight. After extensive washing with PBS, collagen XVII was eluted with 0.1 M glycine, pH 2.5, for 5 min and immediately neutralized with 1 M Tris.
Enzymatic Digestions-For testing the triple-helical conformation with limited trypsin digestion as a probe (23), extracts of COS-7 cells were incubated at increasing temperatures between 4 to 49°C (1°C steps, 3 min each), quickly cooled to room temperature and treated with 10 mg/ml trypsin (Roche Applied Science) for 2 min. The reactions were stopped by adding 10 g/ml soy bean trypsin inhibitor (Sigma).
For removal of N-linked carbohydrate residues, the immunoprecipitated collagen XVII mutants in 0.05 M Tris-HCl, pH 7.7, were treated with 10% ␤-mercaptoethanol for 10 min at 100°C prior to digestion with 10 units/ml N-glycosidase F (Roche Applied Science) or 5 units/ml endoglycosidase H (Endo H) (New England Biolabs, Germany) overnight at 37°C.
RESULTS
Recombinant Collagen XVII Is Expressed and Shed in COS-7
Cells-The experimental system was validated by transfecting COS-7 cells with collagen XVII cDNA and analyzing the recombinant protein. The cells exhibited a distinct immunofluorescence staining of collagen XVII at the cell periphery (Fig. 1A) . Biochemical analysis and immunoblotting with domain-specific antibodies indicated that, similarly to normal human keratinocytes, transfected COS-7 cells contained both full-length collagen XVII and the shed ectodomain (Fig. 1B) . The latter spanned the entire length between the NC16A domain and the distal COOH-terminal region and was structurally very similar, if not identical, to the ectodomain of authentic collagen XVII (Fig. 1B) .
Because we have previously used an inhibitor profile for the discovery that ADAMs shed collagen XVII in human keratinocytes (18), we tested the role of these membrane-bound metalloproteinases in shedding of recombinant collagen XVII in COS-7 cells by using the same set of inhibitors. The metal chelator 1,10-ortho-phenanthroline, the matrix metalloproteinase-and sheddase-targeting hydroxamates BB3103 and BB3241, TIMP-3, and the cell permeable furin inhibitor decanoyl-RVKR-chloromethylketone efficiently prevented shedding. In contrast, no effect was observed with the cysteine peptidase inhibitor E-64, the aspartate protease inhibitor pepstatin or with the serine protease inhibitors AEBSF, aprotinin, or benzamidine. This profile was consistent with involvement of ADAMs. In concert, co-transfection of collagen XVII and murine TACE cDNA led to an ϳ40% increase in ectodomain shedding of collagen XVII, with a concomitant decrease of full-length collagen (Fig. 2B) . Immunoblotting of COS-7 cells with ADAMs antibodies revealed the presence of both the proform and the active form of TACE, and of the active forms of ADAM-9 and -10 ( Fig. 2A) .
To confirm a direct involvement of TACE in shedding of collagen XVII, the expression of the TACE gene was inhibited by small interfering RNAs. Because the turnover time of transmembrane proteins such as TACE is relatively long and dependent on passage through the Golgi apparatus (24, 25) , TACE gene silencing in COS-7 cells was performed in two steps within 4 days. The first transfection with TACE-specific siRNA populations was followed by a co-transfection of collagen XVII cDNA and TACE-siRNA for additional 2 days. This resulted in 85% reduction of TACE protein expression and in 50% reduction of collagen XVII ectodomain shedding, as shown by immunoblotting (Fig. 2C ). These observations are in agreement with our previous findings using TACE-deficient mouse fibroblasts, which showed 40% reduction in shedding of transfected collagen XVII (18) . These data verified that the same proteases release collagen XVII ectodomain from the cell surface in keratinocytes and in COS-7 cells, thereby rendering the COS-7 cell model suitable for the analysis of collagen XVII shedding.
Deletion of Furin Consensus Sequence Does Not Prevent Shedding-Because collagens XIII, XVII, XXIII, and XXV and ectodysplasin A contain a furin consensus sequence within the juxtamembranous linker domain, it has been suggested that furin sheds the ectodomains of these proteins (4, 5, 11, 16, 17) . To obtain more information on the role of furin in the cleavage of collagen XVII, we designed a mutant with a deletion of the furin recognition site. The deletion of the first 18 N-terminal amino acids of the NC16A domain (DEL 490 -507) contains the furin recognition sequence 504 RIRR 507 . Interestingly, this mutant was shed in a manner comparable to wild-type controls (Fig. 3) , indicating that elimination of the consensus sequence has no effect on shedding. On the other hand, shedding of DEL 490 -507 was completely inhibited by the synthetic furin inhibitor (Fig. 3 ). These observations demonstrate that furin or furin-like proteinases are not the primary convertases that release collagen XVII ectodomain from the cell surface, but are needed for activation of other proteinases, such as ADAM-17 or TACE (24, 25) .
Definition of the Sheddase Recognition Region-To determine the sequences required for shedding, eleven additional mutants with defined deletions within the NC16A domain were constructed (Fig. 4 and Table I ). Wild-type collagen XVII and the deletion mutants were transiently expressed in COS-7 cells, and shedding was assessed by immunoblotting. The transmembrane form of collagen XVII was found in all cell extracts (Fig. 4B) , indicating that the deletion mutants were expressed and stable. 
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a PvuI restriction sites are underlined. b Deletion marked as downward arrows (2).
FIG. 2. Expression of ADAMs and shedding of collagen XVII in COS-7 cells.
A, immunoblot of COS-7 cell lysates with antibodies to TACE ectodomain, ADAM-9 ectodomain, and ADAM-10 endodomain. TACE antibodies recognized two distinct protein bands of about 120 and 85 kDa, representing the proform and the active form of the enzyme. ADAM-9 and ADAM-10 antibodies recognized one band of about 79 and 60 kDa, respectively, corresponding to their active forms. Molecular weight markers are shown on the left. B, COS-7 cells were co-transfected with the cDNA for full-length collagen XVII and full-length murine TACE. Aliquots of the cell extract and culture medium were immunoblotted with the antibodies Ecto-5 and NC16A, and the relative density of the signals was analyzed with Quantity One software (upper panel). Co-transfection with TACE markedly increased the amount of the shed ectodomain in the medium and concomitantly decreased the amount of full-length collagen XVII in the cell lysates. C, COS-7 cells were co-transfected with TACE siRNA populations and a cDNA vector coding for full-length collagen XVII as described under "Experimental Procedures." Shedding was assessed after 6 h in FCS-free DMEM media supplemented with 50 g/ml ascorbate. The cell lysates and the media were analyzed by immunoblotting with antibodies against the ectodomain of TACE (a), endodomain of collagen XVII (b; antibody Endo-2), and ectodomain of collagen XVII (c; antibody NC16A). siRNA blocked endogenous TACE expression with an efficiency of about 85% (a). Interference with TACE expression resulted in accumulation of full-length collagen XVII in the cells (b) and strongly reduced release of the ectodomain into the medium (c). The mutant lacking the entire NC16A domain, i.e. amino acids 490 -566 (DEL NC16A) was not shed. Similarly, two other large deletions, of amino acids 508 -547 (DEL 508 -547) and amino acids 504 -558 (DEL 504 -558), prevented shedding. In contrast, most mutants with deletions of up to 20 amino acids, i.e. DEL 508 -520, DEL 521-540, or DEL 540 -566, were shed efficiently. However, one mutant with a deletion of 20 amino acids in position 528 -547 (DEL 528 -547) was not released from the cell surface (Figs. 4 and 5A ). Further analysis of small deletions within amino acid residues 528 -547, namely DEL 527-531, DEL 527-536, DEL 535-540, and DEL 535-546, revealed normal shedding, indicating that the complete stretch containing amino acid residues 528 -547 is important for recognition and cleavage by ADAMs.
Structural Predictions of the NC16A Linker DomainSeveral lines of evidence point to the fact that cleavage by sheddases depends on structural features and steric accessibility of the substrate (26, 27) . Analysis of the secondary structure of the NC16A domain with the PSAAM (Protein Sequence Analysis and Modeling) software (University of Illinois) and the PSIPRED protein structure prediction server of the University College London (28) indicated that this domain contains three ␣ helices (probability 80 -100%), separated by random coil sequences. Further analysis with the computer software COILS (29) showed that the first ␣ helical domain contained a coiled-coil structure motif within the stretch Glu 490 -Ile 508 (Fig. 5A) . The overall net charge of the NC16A domain has been calculated as slightly negative (pI ϭ 5.86; Fig. 5A ).
The secondary structure of the mutants was predicted by the above software. Although the shed mutants showed NC16A domains with neutral to slightly positive or negative net charges in the pI range of 5.2-9.2, two mutants that were not shed, namely DEL 508 -547 and DEL 528 -547, exhibited stronger positive net charges, with pI values of 9.97 and 10.83, respectively. In addition, DEL 508 -547 and DEL 528 -547 formed a new putative amphipathic ␣-helix of about 2.5 turns in length, which displayed a marked asymmetry in the distribution of hydrophilic versus hydrophobic residues along its sides (Fig. 5B ). These observations indicate that, because the tertiary structure of authentic collagen XVII is homotrimeric 
FIG. 4. Collagen XVII/NC16A deletion mutants.
A, all deletion constructs were prepared using PCR with full-length collagen XVII cDNA as a template. The wild-type amino acid sequence of the NC16A domain is indicated at the top. The sequences present in the constructs are shown as white rectangles and the deleted sequences in black. B, shedding of the deletion mutants. All constructs were transfected to COS-7 cells, and the cell extracts and the media were immunoblotted with the antibody Ecto-5. The transmembrane form of collagen XVII is present in all cell extracts, but the shed ectodomain is not detected in the medium of DEL NC16A, DEL 504 -558, DEL 508 -547, and DEL 528 -547.
consisting of three ␣-1(XVII) chains, interactions of the amphipathic elements, or the positively charged stretches, or a combination of both, change the conformation of the linker domain and thus influence the shedding. It should be noted that the third mutant, which was not shed, DEL 504 -558, makes an exception, because it harbors a negative net charge (pI of 5.2) and formed no new amphipathic helix (Fig. 5A) . But in consideration of the large deletion of at least 55 of the 77 FIG. 5 . Structural predictions of the NC16A domain in collagen XVII deletion mutants. A, secondary protein structure prediction based on the amino acid sequence and the comparison of known protein structures with similar amino acid sequences was performed with the computer program PSAAM (University of Illinois) and the PSIPRED protein structure prediction server (University College London, UK), respectively. The amino acid residues of the NC16A domain were indicated as authentic numbers derived from the full-length collagen XVII sequence. Green boxes, ␣-helical elements predicted with high confidence; magenta loops, putative coiled-coil regions; blue bars, random coil regions; and gray boxes, putative amphipathic areas within the ␣-helices (including the residues numbers). The shedding of mutants is indicated with ϩ or Ϫ on the right. B, helical wheels of the putative amphipathic ␣ helices from the deletion mutants DEL 528 -547 and DEL 508 -547. The numbers of the amino acid residues are the same as in A, and the different colors describe the following attributes: black ϭ neutral; red ϭ acidic, green ϭ polar, and light blue ϭ hydrophobic. Both wheels include an asymmetric distribution of hydrophilic versus hydrophobic residues along its side. amino acids, it is likely that the remaining juxtamembranous linker region of 22 amino acids is too short to allow ADAMs recognition and shedding.
Deletion of the Conserved Sequence 490E-507R Is Not Deleterious for Folding of Collagen XVII-A short, conserved sequence adjacent to the plasma membrane has been proposed to be required for trimer formation for transmembrane collagens (13, 17) . This sequence, 495 LKARVDELERIRR 507 , located within the coiled-coil structure motif in the NC16A domain of collagen XVII (Fig. 5A) , was deleted in construct DEL 490 -507. To assess the significance of this sequence for trimerization and subsequent triple-helix folding of collagen XVII, the thermal stability of wild-type collagen XVII and DEL 490 -507 was analyzed using limited trypsin digestion after exposure to increasing temperatures. The melting range of both was very similar (Fig. 6A) , suggesting that the coiled-coil structure motif is not necessary for the formation of a stable triple-helical collagen XVII homotrimer. In contrast, deletions that prevented shedding caused reduction of thermal stability. The mutants DEL NC16A, DEL 504 -558, and DEL 528 -547, showed a clearly lower helix-to-coil transition point than wildtype collagen XVII, indicating that the mutations also led to abnormal folding of the protein (Fig. 6A) .
Hypothetically, faulty protein folding could block the passage of the mutants through the endoplasmic reticulum and thereby apparently abolish shedding. To exclude this possibility, the ability of two deglycosidases, Endo H and peptide N-glycosidase F, to remove N-linked sugars from collagen XVII mutants was assessed (Fig. 6B) . Although N-linked sugars remain sensitive to peptide N-glycosidase F, the majority becomes resistant to Endo H after they are modified in the medial Golgi. After deglycosylation with peptide N-glycosidase, wild-type collagen XVII and all non-shed mutants exhibited a lower molecular weight. However, the fact that the non-shed mutants were resistant to Endo H indicated that they had traversed the medial Golgi and therefore were localized on the cell surface as transmembrane proteins with an extracellular C terminus. FIG. 6 . Thermal stability and deglycosylation of wild-type and collagen XVII mutants. A, COS-7 cell lysates containing either wild-type or mutant collagen XVII were incubated at 4°C or at increasing temperatures shown in each panel for 3 min. Subsequently, the samples were treated with trypsin for 2 min at 37°C, and the reactions stopped with soybean trypsin inhibitor, as described under "Experimental Procedures." Proteolysis was monitored by immunoblotting with the antibody NC16A for wild-type collagen XVII and DEL 490 -507, and the antibody Col15-2 for DEL NC16A, DEL 504 -558, and DEL 528 -547. Trypsin treatment of all variants led to loss of transmembrane collagen XVII (180 kDa) and the intact ectodomain (120 kDa), and resulted in a major intermediate digestion product (90 kDa), which resisted proteolysis between 4 to 35°C (DEL NC16A, DEL 504 -558, and DEL 528 -547) or 41°C (wild-type and DEL 490 -507), and gradually degraded at higher temperatures. Scanning and quantitation of the bands revealed no difference between wild-type collagen XVII and DEL 490 -507, both lost their stability to about 50% at 43°C. In contrast, DEL NC16A, DEL 504 -558, and DEL 528 -547 lost their stability to about 50% already at 36°C. U, undigested sample. B, aliquots of transfected COS-7 cell lysates were treated with N-glycosidase F (PNG F) or endoglycosidase H (Endo H) as described under "Experimental Procedures" and submitted to immunoblot analysis with the antibody Ecto-5. The treatment with N-glycosidase F resulted in faster migration, indicating N-glycosylation of wild-type, DEL NC16A, DEL 504 -558, DEL 504 -547, and DEL 528 -547 collagen XVII (upper panel), whereas the treatment with Endo H had no effect on motility, indicating that the non-shed mutants have traversed the medial Golgi (lower panel).
DISCUSSION
The ectodomains of most collagenous transmembrane proteins are released from the cell surface, but it is not clear whether the same sheddases cleave all of them, or whether different enzymes are involved (1, 4) . On one hand, furin has been proposed to be the physiological sheddase, because many of the proteins contain a furin consensus motif within the linker region (17, 30) . On the other hand, our recent work demonstrated that collagen XVII is shed by proteinases of the ADAMs family. These observations left an open question as to the physiologically relevant sheddases, and their putative roles as primary and secondary actors in a proteolytic cascade. Here we show that interference with TACE expression using siRNA reduces shedding of collagen XVII by about 50%, thereby confirming the role of TACE as a physiological sheddase. Furthermore, deletion of the furin consensus sequence 504 RIRR 507 from collagen XVII has no effect on shedding. Moreover, the deletion does not abolish the inhibitory effect of a furin inhibitor, pointing to the role of furin as an activator of ADAMs. This conclusion is supported by very recent studies by Hirako et al. (31) . Using cell free membrane preparations, they showed that collagen XVII shedding was inhibited by metalloprotease inhibitors but not by furin inhibitors, because intracellular furin activity is present only in living cells.
The recognition of substrates by ADAMs is not fully understood, but it is assumed that sites distal to the active site are involved and that both enzyme and substrate must be membrane-anchored (26). The prototype sheddase, ADAM-17 or TACE, has been extensively studied in this context (19, 32, 33) . Mutations in the primary sequence surrounding the cleavage site in the substrate seem to have little effect on shedding, suggesting that no minimal recognition sequence exists. For example, single or even multiple substitutions of conserved amino acids within the cleavage domain did not significantly affect shedding of L-selectin, a well characterized substrate of TACE (27) . In contrast, a deletion mutant of L-selectin, which retained the native cleavage site was not shed, but replacing the deleted amino acids with five alanine residues restored shedding (27) . Similarly, in case of other TACE substrates like transforming growth factor-␣, TNF-␣, and amyloid precursor protein, most amino acid substitutions in the cleavage region did not inhibit shedding (see Ref. 34) . Instead, structural requirements seem to be important. The sheddases need an unfolded stalk region surrounding the target bond. Juxtamembranous deletions inhibit shedding of several TACE substrates, including amyloid precursor protein (35) , TNF-␣ (36), and TNF-␣ receptors (37, 38) , regardless of whether the sequence at the cleavage site remains intact, if the remaining stalk is shorter than a minimal length, generally about 10 -12 amino acids (19) . Moreover, substrate sequences remote from the actual cleavage site may regulate the proteolysis, as in the case of murine L-selectin, where phorbol 12-myristate 13-acetate-induced shedding is modulated by a distally located epidermal growth factor domain (34) .
The present studies on collagen XVII shedding requirements demonstrated that, similarly to the above TACE substrates, large deletions leaving a juxtamembranous stalk of only 14 -18 amino acids inhibited shedding. In addition, the stretch of 20 amino acids in position 528 -547 was shown to be important for collagen XVII cleavage by ADAMs. Because the precise N terminus of the soluble ectodomain of collagen XVII remains unknown, the vicinity or distance of amino acids 528 -547 to the scissile bond cannot be determined with certainty. However, it is intriguing that this stretch contains the sequence 531 AGADLDKIGLHSDSQE 546 , which was reported to represent the N terminus of LABD97, the 97-kDa linear IgA dermatosis autoantigen (39) . This antigen was first isolated from human skin and was later shown to be derived from the ectodomain of collagen XVII (39, 40) . Therefore, it appears feasible that the scissile bond resides within the deleted stretch.
In any case, the elimination of amino acids 528 -547 from the NC16A domain causes structural changes in the ADAM recognition site. Secondary protein structure predictions showed that this and another mutant, which are not shed (DEL 508 -547), has a positive net charge (instead of negative net charge in the wild-type) and a novel putative amphipathic element within the C-terminal ␣-helix of the NC16A domain. The coexistence of three amphipathic elements in the collagen XVII homotrimer accentuates the conformational changes and is likely to influence the interaction with ADAMs. Thus, our observations indicate that structural motifs play an important role in the recognition and cleavage by ADAMs, and place collagen XVII into the same group with other TACE substrates, including amyloid precursor protein, TNF-␣, and L-selectin.
An intriguing additional possibility, resulting from the fact that sheddases recognize cleavage sites on the basis of structural motifs, is that the cleavage site in collagen XVII, and other substrates, may vary under different biological conditions. For example, binding of different ligands at different times may influence the tertiary structure of the ectodomain and thus cause variation in the position, which is proteolytically processed. Future studies on shedding of ligand-bound and -free collagenous transmembrane proteins must clarify this question.
The deletion mutants were also employed to study collagen XVII folding. In contrast to classic fibril-forming procollagens, in which triple-helix folding is nucleated in the C terminus and proceeds in a C 3 N-terminal direction (14, 41, 42) , the folding of transmembrane collagens XIII and XVII has been suggested to initiate at the N terminus and to proceed toward the C terminus (13, 17, 43) . Subsequently, based on sequence homology, a common triple-helix nucleation domain for collagenous transmembrane proteins was suggested by Snellman et al. (17) .
In collagen XVII, this nucleation sequence, 495 LKARVDE-LERIRR 507 , is located within the NC16A domain. To assess its significance for folding, we deleted amino acids 490 -507 from the NC16A domain. Unexpectedly, the deletion had no influence on the thermal stability of the mutant collagen XVII, indicating that this had folded into a stable triple-helix. Studies with recombinant fragments spanning single domains of collagen XVII, or two neighboring domains, support this finding and argue that the nucleation domain may not be needed for trimerization and triple-helix folding of collagen XVII. Areida et al. (13) produced a recombinant, N-terminally deleted, secreted ectodomain of collagen XVII, which lacked the first 27 amino acids (residues 490 -516), including the nucleation domain. This truncated ectodomain adopted stable triplehelical conformation with a melting temperature of 41-43°C, comparable to authentic full-length collagen XVII (11) . In concert with this, short recombinant collagen XVII fragments without the nucleation domain can form stable triple helices (12, 13) . The largest collagenous domain Col15, expressed as a eukaryotic recombinant fragment, formed a triple helix with a T m of 26.5°C (12) , and a longer fragment, which contained both Col15 and the adjacent amino acids 527-565 of the NC16A domain, but not the nucleation domain, formed a triple helix with the melting temperature of 35°C (13) . Taken together, the conserved triple-helix nucleation domain (17) is not required for folding of collagen XVII. Instead, other coiled-coil sequences within the NC16A domain can stabilize trimerization and subsequent triple-helix formation of this collagen. This assumption was supported by the above analyses of helix-to-coil transition, which demonstrated that the deletions preventing shedding affected protein folding and destabilized the triple helix of collagen XVII.
